BlackRock’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$98.1M Sell
12,131,359
-456,419
-4% -$3.69M ﹤0.01% 2037
2025
Q1
$105M Sell
12,587,778
-232
-0% -$1.94K ﹤0.01% 1943
2024
Q4
$99.7M Buy
12,588,010
+177,458
+1% +$1.41M ﹤0.01% 2070
2024
Q3
$103M Buy
12,410,552
+1,128,122
+10% +$9.39M ﹤0.01% 2043
2024
Q2
$71.6M Buy
11,282,430
+2,118,258
+23% +$13.5M ﹤0.01% 2200
2024
Q1
$55.5M Buy
9,164,172
+317,751
+4% +$1.93M ﹤0.01% 2347
2023
Q4
$53.7M Buy
8,846,421
+813,912
+10% +$4.94M ﹤0.01% 2387
2023
Q3
$33.9M Buy
8,032,509
+24,513
+0.3% +$103K ﹤0.01% 2591
2023
Q2
$24.8M Buy
8,007,996
+778,523
+11% +$2.41M ﹤0.01% 2838
2023
Q1
$10M Sell
7,229,473
-67,150
-0.9% -$93.3K ﹤0.01% 3250
2022
Q4
$14.5M Buy
7,296,623
+235,217
+3% +$468K ﹤0.01% 3138
2022
Q3
$14.3M Sell
7,061,406
-393,996
-5% -$796K ﹤0.01% 3170
2022
Q2
$23.7M Buy
7,455,402
+372,700
+5% +$1.19M ﹤0.01% 2940
2022
Q1
$29.5M Buy
7,082,702
+91,072
+1% +$380K ﹤0.01% 2864
2021
Q4
$33.5M Buy
6,991,630
+44,741
+0.6% +$214K ﹤0.01% 2898
2021
Q3
$37.1M Sell
6,946,889
-146,938
-2% -$785K ﹤0.01% 2824
2021
Q2
$36.3M Sell
7,093,827
-570,965
-7% -$2.92M ﹤0.01% 2868
2021
Q1
$51.6M Buy
7,664,792
+257,997
+3% +$1.74M ﹤0.01% 2552
2020
Q4
$33.8M Sell
7,406,795
-918,690
-11% -$4.2M ﹤0.01% 2662
2020
Q3
$32.3M Sell
8,325,485
-361,192
-4% -$1.4M ﹤0.01% 2501
2020
Q2
$41.3M Sell
8,686,677
-613,296
-7% -$2.92M ﹤0.01% 2344
2020
Q1
$32.4M Sell
9,299,973
-94,651
-1% -$329K ﹤0.01% 2307
2019
Q4
$45.3M Buy
9,394,624
+1,866,574
+25% +$9M ﹤0.01% 2401
2019
Q3
$21.8M Buy
7,528,050
+1,133,127
+18% +$3.29M ﹤0.01% 2737
2019
Q2
$45.9M Buy
6,394,923
+549,217
+9% +$3.94M ﹤0.01% 2349
2019
Q1
$82.8M Sell
5,845,706
-208,021
-3% -$2.95M ﹤0.01% 1980
2018
Q4
$81.9M Buy
6,053,727
+121,800
+2% +$1.65M ﹤0.01% 1944
2018
Q3
$132M Buy
5,931,927
+123,844
+2% +$2.75M 0.01% 1772
2018
Q2
$95.3M Buy
+5,808,083
New +$95.3M ﹤0.01% 1958